Abstract-We asked whether balloon-injured neointima formation in the presence of high/low serum cholesterol (CT) levels might be affected by dietary supplementation with fish oil (FO). To test this hypothesis, we examined the differentiation, proliferation, or apoptosis profile of smooth muscle cell (SMC) and adventitial cell response to a mild injury induced via a Fogarty catheter in the carotid artery of adult rabbits that had been fed a standard chow or 0.5% CT-enriched diet starting 4 weeks before the lesion. One week before surgery, animals received FO supplementation. This regimen was continued for the following 3 weeks. The effect of FO on the early proliferative/migratory response of carotid SMCs was also examined in 2-and 7-day-injured normocholesterolemic rabbits. As controls, animals subjected to 3-week endothelial injury and animals kept on a 7-week CT diet were used. Carotid cryosections from the various animal groups were evaluated for morphometry (image analysis), differentiation (immunofluorescence with monoclonal antibodies specific for smooth muscle markers, ie, myosin isoforms, SM22, and fibronectin), proliferation (bromodeoxyuridine incorporation), and apoptosis (terminal deoxynucleotidyl transferase-mediated dUTP nick endlabeling). FO treatment significantly reduced the development of intimal thickening in normocholesterolemic rabbits but had no efficacy in the presence of relatively higher serum CT levels. At day 2 (adventitia) and day 7 (neointima, media, and adventitia), the proliferation index of SMCs in FO-treated injured rabbits was markedly lower than in untreated injured controls. Concomitantly with the antiproliferative effect, FO was able to decrease the size of 2 cell types involved in the cell growth response to endothelial injury, namely, the "fetal-type" medial SMC subpopulation and the fibroblast-derived adventitial myofibroblasts. Thus, in our experimental conditions, a low CT level is a permissive condition for FO to prevent neointima formation to a considerable extent. This event is attributable to the early postinjury effect of FO on SMC/adventitial cell proliferation/differentiation patterns. Key Words: smooth muscle cells Ⅲ adventitia Ⅲ fish oil Ⅲ endothelial injury Ⅲ atherogenesis T he low occurrence rate of coronary heart disease in fish-consuming populations has raised the possibility that an increased consumption of the n ()-3 polyunsaturated fatty acids (PUFAs) might be able to decrease the development of atherosclerosis in the vascular system. 1-5 Despite the expectancy raised by epidemiological studies, 3,5 contrasting results have been reported on the efficacy of FO as an antiatherogenic agent (in experimental animals 6 -17 ) and antirestenotic drug (in clinical trials 18 -26 ). The experimental studies published so far focused almost exclusively on the regressive capacity of PUFA/FO on atherosclerotic lesions in different models (rabbit, swine, nonhuman primates) and conditions (composition, dose, time of application, duration of PUFA/FO treatment, different ratio of polyunsaturated versus saturated fatty acids, isocaloric or nonisocaloric fatty acid substitutions).
T he low occurrence rate of coronary heart disease in fish-consuming populations has raised the possibility that an increased consumption of the n ()-3 polyunsaturated fatty acids (PUFAs) might be able to decrease the development of atherosclerosis in the vascular system. [1] [2] [3] [4] [5] Despite the expectancy raised by epidemiological studies, 3, 5 contrasting results have been reported on the efficacy of FO as an antiatherogenic agent (in experimental animals 6 -17 ) and antirestenotic drug (in clinical trials 18 -26 ). The experimental studies published so far focused almost exclusively on the regressive capacity of PUFA/FO on atherosclerotic lesions in different models (rabbit, swine, nonhuman primates) and conditions (composition, dose, time of application, duration of PUFA/FO treatment, different ratio of polyunsaturated versus saturated fatty acids, isocaloric or nonisocaloric fatty acid substitutions).
There are few data concerning the preventive effect of FO on neointima formation after endothelial lesion. 27 Given that the wide array of effects consequent to PUFA/FO supplementation are all pertinent to the initial phase of atherogenesis, we examined the effect of FO dietary supplementation on the early response of vessel wall to endothelial injury. In this investigation, particular emphasis is given to the parietal cell types to which previous and recent studies 28 -30 assign a key role in neointima formation and whose activation occurs soon after lesion: SMCs 28 -30 and adventitial cells. [31] [32] [33] Because medial SMCs are a structurally and functionally heterogeneous population, 34 -36 it might be that FO action is carried out selectively on distinct SMC subtypes, possibly influencing the specific differentiation profile of these cells. It is also known that medial SMCs are phenotypically unstable 34 -36 and are able to modify their structural and functional commitment soon after lesion, in association with the alteration in the proliferation and apoptosis profile and before the migration "wave" to the subendothelial space occurs. 29, 35 If FO may potentially be able to influence these processes in the media/neointima, it is reasonable to assume that the marine oils may also affect the phenotypic stability of adventitial fibroblasts (ie, the inherent property of these cells of becoming myofibroblasts [31] [32] [33] ) once the wall is damaged. These cells are considered to be a hybrid fibroblast-SMC phenotype or an intermediate cell phenotype between the 2 cell types. 32 We have also sought to compare the potential efficacy of FO treatment on injured carotid arteries in the presence of high or low serum CT levels. Because lipid accumulation in the vascular wall is preceded by intimal SMC proliferation 37, 38 and LDL-CT can alter the in vitro phenotypic 39 and the proliferative 40 level of SMCs, the possibility exists that this atherogenic risk factor may interfere with the putative antineointima action of FO. 27 Using a combined morphometric and immunocytochemical approach, we determined that the efficacy of FO in preventing neointima formation is restricted to the normocholesterolemic rabbit. A possible mechanism through which FO may exert its effect is also delineated in this study, ie, by reducing the 2 arterial wall cell populations that are markedly increased in cell growth response to endothelial injury, the "fetal"-type medial SMCs and the adventitial myofibroblasts.
Methods Animals
Sixty-two male 3-to 4-month-old New Zealand White rabbits were divided into 6 animals groups (see Figure 1) . A different feeding protocol (duration, 7 weeks) was applied for the various groups: the standard chow diet and standard chow diet containing 0.5% CT (CT feeding). A low-calorie 2RB15 "certificate" standard diet chow containing 2.47% fat and 13.16% protein was purchased from Mucedola. Animals received FO supplementation starting 1 week before surgery up to the end of the experiment (week 7). FO supplement (Esapent; Pharmacia & Upjohn) containing 85% of eicosapentaenoic and docosahexaenoic acids in the ratio of Ϸ0.9% to 1.5% to Ϸ84%, respectively, was administered by an orogastric gavage device at a dosage of 0.35 g ⅐ kg Ϫ1 ⅐ d Ϫ1 . At 4 weeks from the beginning of the experiments, some groups of animals were subjected to endothelial lesion. To study the early response to wall damage in the presence or absence of FO supplementation, 2 subgroups of animals were euthanized on days 2 and 7 after lesion. A control group was composed of rabbits with an intact carotid artery subjected to a standard diet and without FO treatment. 
Endothelial Lesion
Animals were anesthetized with sodium pentobarbital (30 mg/kg; sodium pentothal; Abbott Laboratories) and urethan (70 mg/kg) administered via a marginal ear vein. A 2F Fogarty embolectomy catheter (Baxter Healthcare Co) was introduced through an aseptic neck incision produced in the facial branch of the external left carotid artery and positioned approximately at the origin of the common carotid artery. An acute balloon injury was performed by inflating the balloon with 0.2 mL saline solution and then gently pulling it back along the entire length of the common carotid artery with constant rotation. The procedure was repeated 3 times. The catheter was then removed, the artery branch ligated, and the surgical wound closed. The animals were allowed to recover under observation before being placed in their cages. Injection of Evans blue dye 3 hours after surgery confirmed the homogeneous removal of endothelium from injured carotid artery. Histological examination of this area revealed a marked structural alteration of SMCs in the presence of a substantially intact wall organization (not shown). Because the lesion apparently did not involve disruption of the medial integrity and a direct contact of the blood with the adventitia, we define the impact of the lesion on the carotid wall as "mild" injury. 41 At the end of the study period (days 2, 7, and 21), animals were killed under pentobarbital anesthesia. The left common carotid artery and the contralateral vessel were excised with great care to avoid any damage to the adventitial layer. The vessel segments were then perfused with OCT mounting medium (Tissue Tek, Miles Inc) under constant pressure and then inserted into the lumen of the thoracic aorta. The mounted block was immersed in liquid nitrogen and stored at Ϫ80°C. The contralateral carotid artery was used as control.
Determination of Serum Lipoproteins
Total serum CT and triglycerides were determined by the CHOD-PAP method and analyzed with an automatic Hitachi 717 analyzer (Hitachi/Boehringer Mannheim).
Bromodeoxyuridine Labeling
Bromodeoxyuridine (BrdU; 30 mg/kg IP; Boehringer Mannheim) dissolved in PBS, pH 7.2, was injected 12 and 24 hours before euthanasia (at 2 and 7 days and 3 weeks).
Morphometric Measurements and Image Analysis
Calculation of tissue areas as well as counting of BrdU-incorporating cells, fetal-type medial SMCs, adventitial myofibroblasts, and total cell number were carried out by computerized image analysis systems. For tissue area calculations, transverse cryosections 10 m thick prepared from each carotid segment were fixed in 1.5% formaldehyde in PBS and then stained with hematoxylin-eosin. Morphometric analysis of the medial and intimal areas was assessed in carotid specimens from each animal with a computerized planimetry system (VIDS V). Measurements were carried out blinded on 6 sections per animal. The ratio of intimal area/medial area was taken as index of carotid neointima formation. Data expressed as meanϮSD were compared by 2-way ANOVA. Then statistically significant data were corrected with the Bonferroni unpaired t test for direct post hoc comparisons. A probability of PϽ0.001 was considered statistically significant.
A detailed blinded quantification of fetal-type medial SMCs 35 and adventitial myofibroblasts 32 with the total hematoxylin-positive cell nuclei. Cryosections were viewed with a high-resolution, charged-coupled device (CCD), TV video camera (Sony DXC-102P) attached to a Zeiss microscope (UMSP80) fitted with an ϫ25 objective. The resulting images were contrast-enhanced, digitalized, and measured with an AT-IBAS Image Analysis System (Kontron). According to these settings, the size of the image analyzed was 26 000 m. 2 After image acquisition and contrast enhancement, the thresholding procedure was applied to measure in each field the total area covered by negative and positive cytoplasm, respectively. The threshold cytoplasm antigen level for medial and adventitial cells was evaluated by use of a control slide in which the primary antibody was omitted in the immunoperoxidase processing of cryosections. The mean nuclear area of both positive and negative nuclei was also estimated by measuring for each sample 15 randomly chosen nuclear profiles. The mean number of nuclei was then counted for each sample by calculation of the ratio between the mean total area covered by positive or negative nuclei and the corresponding mean nuclear area. The mean number of cells was determined by the same procedure using the mean cellular area value.
The BrdU-incorporation profile in the various types of carotid arteries was studied by use of an immunoperoxidase protocol and the procedure described above for the AT-IBAS Image Analysis System. Twenty-four separate microscopic fields were measured for each sample. Counting of red (BrdU-incorporating) and of bluevioletϩred (total number) nuclei was expressed as meanϮSD and normalized to the area unit (mm 2 ). Labeling index (per mm 2 ) expresses the ratio between BrdU-positive nuclei and the total number of nuclei for each animal group.
Statistical analysis of data was carried out by 2-way ANOVA followed, when statistically significant, by Bonferroni's correction performed with the unpaired t test for direct post hoc comparisons. A probability of PϽ0.05 was considered statistically significant.
Semiquantitative evaluation of apoptotic cells in the carotid arteries from normocholesterolemic, hypercholesterolemic, and injured animals was determined by counting the yellow terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL)-positive versus the TUNEL-negative nuclei as they appeared after fluorescein labeling. Cryosections were observed with a Zeiss Axioplan microscope equipped with a Hamamatsu CCD camera coupled with a Power Macintosh computer. Images were captured by a Hamamatsu frame grabber and analyzed with Optilab 2.5.1 software. 42 
Antibodies
The following monoclonal antibodies were used in this study: SM-E7 anti-SM-type myosin heavy chain (MyHC) and NM-F6 and NM-G2 anti-NM MyHC. 35 As previously reported, the SM-E7 reacts with both SM1 and SM2 SM-type MyHC, whereas NM-G2 and NM-F6 are able to differently recognize an antigenic epitope localized in the platelet-type MyHC isoforms MyHC-A pla2 and MyHC-A pla1 , 35 respectively. IST-9 anti-fibronectin EIIIA isoform 43 (EIIIAFn; a generous gift of Dr L. Zardi, Istituto Nazionale per la Ricerca sal Cancro, Genoa, Italy), RAM anti-monocyte-macrophage (Dako, Dakopatts), and anti-SM-specific E-11 anti-SM22 33, 44 antibodies. SM-type ␣-actin was purchased from Sigma Chemical Co, and anti-vimentin was from Boehringer Mannheim.
Immunocytochemistry
Primary antibodies (except for the E-11) were applied to freshly cut unfixed cryosections as previously described. 33, 44 For anti-SM22 antibodies, cryosections were first fixed in 1.5% formaldehyde in PBS, pH 7.2. 33, 44 In these procedures, the secondary antibody was the anti-mouse IgG coupled with rhodamine isothiocyanate or horseradish peroxidase. In the latter circumstance, bound IgGs were revealed by incubation in aminoethylcarbazole solution. Counterstaining was performed with Mayer's hematoxylin. Controls were made by omitting the primary antibody and using nonimmune IgG followed by the secondary antibody. Nuclei were stained with bis-benzimide (Hoechst 33258).
BrdU-incorporating nuclei in normal and injured vascular tissue from end-labeling experiments were detected with a specific anti-BrdU antibody (Dako) according to the procedure reported in Reference 45. Negative and positive BrdU-incorporating tissues (myocardium and small intestine, respectively) from the same animals as used for BrdU labeling of injured vessels were used as controls.
TUNEL Analysis
Freshly cut cryosections from normal and injured carotid wall were processed for apoptosis by the TUNEL procedure with the Boehringer Mannheim kit. The experiments and the negative control were performed according to the manufacturer's instructions, including an incubation with 3% citric acid solution and omitting the proteinase K pretreatment as recommended by some authors. 46, 47 In addition, the cardiac muscle tissue and a leiomyosarcoma 48 were used as alternative negative and positive controls, respectively.
Results

Effect of FO on Serum Lipids
Rabbits belonging to the various groups examined remained healthy throughout the study period. At the end of the experiments, there was no significant difference among the groups with respect to body weight (average, 3 kg/animal).
The total serum CT and triglyceride levels present in injured rabbits subjected to the various treatments/feedings is shown in the N; nϭ4) , cholesterol-fed (CT; nϭ4), injured (B), injuredϩFO-treated (BϩFO; nϭ11), injuredϩCT-fed (BϩCT; nϭ9), and injuredϩCT-fedϩFO-treated (BϩCTϩFO; nϭ8) rabbits. Two-way ANOVA followed by post hoc Bonferroni's test. PϽ0.001. group). As expected, the values shown by the injured animals kept on standard chow diet are very similar to those of uninjured normocholesterolemic rabbits. Figure 2 shows the results obtained with the morphometry measurements on cryosections from the various carotid arteries obtained from the 6 scrutinized animal groups. Importantly, the segment of carotid artery used in this study did not show, under normal cholesterol diet regimens, morphometrically detectable tunica intima ( Figures 2 and 3) ; it was also selected because it is hardly susceptible to developing histologically visible atherosclerotic lesions at the CT feeding condition used here and despite a relatively high serum CT D) . On FO treatment, the SM-E7 is still homogeneously reactive, whereas for the other antibodies, the reactivity is particularly evident in the subendothelial region. e indicates endothelium. Barϭ100 m.
Effect of FO on Carotid Lesion Area
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the efficacy of FO supplementation on intimal thickening development is restricted to the animal group kept on a standard diet.
Effect of FO on SMC Composition 3 Weeks After Lesion
The potential effect of FO on the differentiation pattern of carotid SMCs was studied by immunophenotyping the expression of SM-and NM-type MyHC isoforms in the injured vessel wall from normocholesterolemic rabbits. The combined use of SM-E7, NM-G2, and NM-F6 anti-myosin antibodies in developing and adult rabbit arterial SMCs has allowed us to identify 3 categories of SMCs, namely, "fetal" (labeled with SM-E7ϩNM-F6, ie, containing SMϩMyHC-A pla1 myosin), "postnatal" (labeled with SM-E7ϩNM-G2, ie, containing SMϩMyHC-A pla2 myosin), and "adult" (labeled F) . The E-11 reactivity in the injured carotid artery is weak and localized near the lumen (star in G), whereas it disappears after FO supplementation. In the injured wall, IST-9 staining is diffused to the central part of the media, whereas it is localized mainly to the subendothelial region on FO treatment. v indicates vasa vasorum. Barϭ100 m.
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with SM-E7 only, ie, containing SM myosin exclusively). In this investigation, we also included 2 other antibodies: IST-9, whose recognized antigenic target (EIIIA fibronectin), in our model, permits the identification of "dedifferentiated" SMCs;
and E-11, specific for a SMC lineage-specific marker (the SM22 isoform complex 33, 50, 51 ) . Figures 3 and 4 show the results obtained with the immunophenotyping study performed on cryosections from the normocholesterolemic intact (N group; Figure 3 ) and 3 weeks-injured/injuredϩFO treatment (B/BϩFO group) (Figure 4) rabbits. In uninjured carotid artery (see Figure 3) , the majority of cells are adult ( Figure 3A) , some are postnatal ( Figure 3B) , and none are fetal ( Figure 3C ). SM22 labels all medial SMCs, although with different intensities (Figure 3D ). IST-9 is localized exclusively to the subendothelial cells (Figure 3E) , where the majority of postnatal-type SMCs are accumulated ( Figure 3B) .
In injured carotid arteries, monocyte/macrophage contaminants are absent from both the neointima and the underlying media. 33 Neointimal SMCs in the injured vessels are represented by postnatal SMCs (Figure 4A and 4B), being almost negative or weakly positive with NM-F6 ( Figure 4C ) or E-11 ( Figure 4D ), respectively. Fetal-type fibronectin is expressed exclusively in the neointima ( Figure 4E) . Compared with the uninjured group, in the media subjacent to the neointima of carotids from the injured group there is a marked decrease in the SM22 content ( Figure 4D ) and a weaker postnatal-type immunoreactivity ( Figure 4B ). FO treatment of the injured carotid does not substantially modify the SMC immunophenotypic patterns in the media/neointima compared with the injured vessels.
Effect of FO on SMC Composition 2 and 7 Days After Lesion
Because the possibility exists that the anti-intimal thickening action of FO may be exerted earlier in the postinjury period, ie, in close relationship with the proliferation and/or migratory phase of SMC response to the endothelial injury, 52, 53 we studied in greater detail the SMC phenotypic pattern at days 2 and 7 from the induction of the lesion. Figure 5 shows the results obtained with SMC immunophenotyping on carotid cryosections from day 2 injured and injuredϩFO-treated rabbits. At this time, a neointima layer is not yet visible, and the major changes occur at the level of the media and adventitia (see also Reference 33) . In addition, very rare monocytes/macrophages are present near the internal elastic lamina, which disappeared after FO treatment (not shown). In injured media, a large number of fetal SMCs are present ( Figure 5A , 5C, and 5E), whereas with FO treatment ( Figure  5B , 5D, and 5F), most SMCs now express the postnatal phenotype. The rare strong subendothelial SM22-positive cells ( Figure 5G and 5H ) and the fibronectin-containing cells ( Figure 5I and 5J) have almost disappeared. Similar data are obtained for day 7-injured animals (not shown). The fact that FO treatment induces a decrease in the fetal SMCs is documented by the bar graph shown in Figure 6 . Quantification of this medial cell population indicates that this phenotypic change occurs in a statistically significant manner at approximately day 2 after injury. These data, along with those presented above, would indicate that 1 effect of FO treatment is the shift toward a relatively more differentiated SMC phenotype in the medial layer.
Effect of FO on Adventitial Cells
Considering the role that adventitial cells might play in our model, we studied whether the locally activated cells, ie, the myofibroblasts [31] [32] [33] 41 (identified on the basis of SM-type ␣-actin and vimentin) are distributed differently in injured FO-treated versus untreated animals. Figure 7 shows that the FO supplementation induces a marked decrease in the actinpositive myofibroblasts in the adventitia. Vimentin immunostaining resembles the actin pattern very closely (not shown). Cell counting of VD-myofibroblasts 54 performed on carotid cryosections from rabbits injured on days 2 and 7 and injuredϩFO rabbits confirmed that a considerable decrease of SM-type ␣-actin-containing cells occurs after FO treatment in the carotid adventitia (Figure 8 ).
Effect of FO on BrdU Incorporation Level
To establish whether the early (2/7 days) phenotypic changes and the late (3 weeks) morphometric gain occurring with FO treatment in endothelium-injured carotid wall is related to a proliferation profile of cells in the carotid media and adventitia, we performed a BrdU-incorporation study. Figure 9 shows that FO treatment is able to significantly reduce the number of BrdU-positive cells in adventitia at both day 2 and day 7 postinjury (from 73.2Ϯ38.2 to 27.7Ϯ24.5 at day 2; from 9.7Ϯ11.4 to 0.0Ϯ0.0 at day 7). FO can also decrease the number of BrdU-reactive cells in the media (from 18.7Ϯ13.1 to 1.6Ϯ3.1) and neointima (from 48.9Ϯ17.5 to 16.3Ϯ8.8) at day 7 after the induction of lesion. The BrdU incorporation levels attained by neointima and media at 3 weeks after injury is similar to the control rabbit (N group) reported in Reference 55. Figure 10 shows the tissue-specific distribution of BrdU-positive cells at days 2, 7, and 21 after injury. The majority of BrdU-incorporating cells are localized to the adventitia soon after lesion, whereas at day 7, adventitia is almost deprived of positive cells in favor of the innermost layer of the media and the developing neointima. FO treatment markedly reduces the presence of BrdU-positive cells in all the wall compartments. By 3 weeks after injury, no positive cells can be detected, irrespective of the experimental condition.
Effect of FO on Apoptosis Distribution Pattern
Apoptosis distribution in carotid cryosections from uninjured, injured, and injuredϩFO-treated animals is shown in Figure   Figure 8 . Effect of FO treatment on SM-type ␣-actin-containing adventitial cells expressed as percentage (ϮSD) of the total cell number in days 2-and 7-injured carotid artery. B indicates injured and BϩFO, injuredϩFO-treated rabbits. Two-way ANOVA and post hoc Bonferroni's test. nϭ4 (B, days 2 and 7); nϭ5 (BϩFO, day 2 and 7). 
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11. In the intact vessel, TUNEL-positive cells are present almost exclusively in the adventitia ( Figure 11A ), whereas at day 2, in both FO-treated and untreated animals, numerous positive cells are found in the endothelial layer but not in the medial or adventitial layer ( Figure 11B and 11C) . At days 7 ( Figure 11D and 11E) and 21 ( Figure 11F and 11G) after surgery, Ͻ1% of SMCs are apoptotic, irrespective of the tissue layer or the treatment. 
Discussion
The results of this study indicate that lesion area development is significantly reduced after 3 weeks of FO only in the animal group fed a low-cholesterol diet. In fact, in the injured hypercholesterolemic animal group, the efficacy of FO treatment as lesion antagonist is dramatically lost. We are in concordance with Chen et al, 27 who reported that a more severe effect of FO on the myointimal growth in the injured rabbit abdominal aorta is achieved in the presence of low CT levels. Our data are also in keeping with the results obtained by Sassen et al 14 and Fincham et al, 13 who found that in porcine injured arteries, the retardation in the progression or the lack of regression (ie, stabilization) of atherosclerotic lesions is related to the plasma CT content.
The serum CT-dependent efficacy of FO treatment in endothelium-injured arterial wall might be related to the differential cellular assortment of the lesion at low or high CT level, ie, the number of monocytes-macrophages/lymphocytes 1,2 versus SMCs 33 and/or the amounts of native versus oxidized LDL. Although in our experimental conditions, FO treatment in injured rabbits subjected to short-term CT feeding and FO supplementation was unable to substantially alter the total serum CT level (Table) , it might be that LDL particles accumulated at the site of the lesion were present in an abnormal quantity or were qualitatively prone to be chemically modified. 56 Oxidized LDL can stimulate arterial SMC growth indirectly, via induction of growth factors (eg, platelet-derived growth factor) from the same or other cells (macrophages and endothelial cells 28, 29 ), or Figure 11 . Apoptotic cell distribution in cryosections from uninjured carotid artery (A); days 2-(B), 7-(D), and 21-(F) injured carotid artery from animals without FO treatment (ϪFO); and days 2-(C), 7-(E), and 21-(G) injured carotid artery from animals treated with FO (ϩFO). Note that no apoptotic (yellow) cells are seen in the media (m) from uninjured vessel, although rare positive cells are detectable in the adventitia (a, arrowheads). At day 2 (B), some apoptotic cells can be seen in the endothelium (e; arrowheads), in the muscle (double arrowheads) immediately beneath the internal elastic lamina (iel), and in the adventitia. At later stages after injury, the apoptosis level is scarce in both the treated and untreated carotids (media, neointima [it], or adventitia). Barϭ130 m.
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directly, via activation of the pathway of mitogen-activated protein kinases. 57 Triglyceride levels did not show appreciable changes in the animal group treated with FO, in keeping with other reports. 27, 58 The study of SMC differentiation has furnished some indications about the mechanism through which FO acts at low CT concentrations. We purposely selected a segment of the rabbit common carotid artery that is histologically unable to develop an atherosclerotic plaque when subjected to the diet regimen used in this study. 49 In addition, this vessel is relatively enriched with postnatal-type SMCs 35, 37 and thus is potentially at risk for developing SMC growth and migration. 35, 37 Twenty-one days after injury, in the FO-treated group, there was a slight increase in the differentiation pattern of both neointimal and medial SMCs, although a complete maturation was not achieved (high signal for fetal fibronectin 59 and scarce presence of SM22 60 ; see Figure 4 ). In the early phase of response to injury (days 2 and 7), the effect of FO treatment became more evident. Here, both the general organization of arterial wall and the degree of SMC differentiation were markedly improved. In particular, the media contained fewer fetal-type SMCs ( Figure 5 ), which in the injured carotid artery are particularly high and are directly implicated in neointima formation 35 ( Figure 5A , 5C, and 5E). Similarly, the adventitia from injured-FO-treated artery contained fewer vimentin-and SM ␣-actin-containing myofibroblasts (the VA myofibroblasts 54 ), which are known to participate in the medial cell incorporation/neointima formation. [31] [32] [33] Taken together, these findings are fairly consonant with our previous data about the correlation existing between the reduction of plaque formation induced by calcium channel blockers and the shift toward more differentiated SMCs 61-63 (both decrease in the fetal-type and increase in the adult-type SMCs).
The change in the phenotypic pattern of medial SMCs induced by FO treatment soon after injury is strictly linked to the modification of proliferation indices in the adventitia and media, but not the apoptotic cell distribution, which remains substantially unaffected compared with the injured carotid artery. We cannot rule out completely the possibility that FO may influence apoptosis, inasmuch as the burst of this event seems to occur within hours after injury. 47 Interestingly, a decrease of the adventitial myofibroblast content in FOtreated day 2-injured carotids is mirrored by a marked decrease in the proliferation ability of these cells, whereas the BrdU-incorporation level of the medial SMCs remains unaffected. It is at day 7 postinjury that adventitia, media, and neointima all display a much lower propensity to proliferate on FO treatment. Recent experiments indicate that neointimal SMCs may derive from the dedifferentiated or phenotypically modulated medial SMCs and by recruitment and incorporation of adventitial myofibroblasts (porcine coronary arteries and rabbit carotid artery). 28 -33 Thus, the antiproliferative effect of FO treatment on the injured carotid seems to be dual, affecting both medial and adventitial cells. In particular, the reduction of proliferative index exerted by FO on adventitial cells suggests that the local cell conversion pathway from fibroblast to myofibroblast, [31] [32] [33] 41 as part of the response-toinjury process, may be controlled by FO.
Although the results of this study might have important implications for the still-debated use of FO as an antirestenotic agent, some caution must be taken. First, the dose used is certainly not in the range of that used up to now in human studies. Second, the different lipid metabolism in rabbit versus human does not allow any firm conclusions about the real efficacy of FO as an antiatherogenic or antistenotic agent. Third, the relatively short period of FO pretreatment that precedes the cellular wall response triggered by the endothelial lesion might have led to an underestimation of FO efficacy. However, on the basis of the data presented here and those of Chen et al, 27 we are in a position to suggest that relatively high doses of FO might have a short-term beneficial effect on restenosis soon after angioplasty. Certainly, this hypothesis needs to be preliminarily tested in experimental settings in which FO treatment is applied to animals with a well-developed atherosclerotic plaque at the time of angioplastic intervention.
